Recent approaches to identifying biomarkers for high-risk stage II colon cancer (Q38041974)

27 August 2017

Recent approaches to identifying biomarkers for high-risk stage II colon cancer (English)

1 reference

27 August 2017

0 references

Takashi Akiyoshi

1

1 reference

PubMed ID

22961195

27 August 2017

Takashi Kobunai

series ordinal

2

1 reference

PubMed ID

22961195

27 August 2017

Toshiaki Watanabe

series ordinal

3

1 reference

27 August 2017

9 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

42

1 reference

27 August 2017

1037-1045

1 reference

27 August 2017

11

1 reference

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

27 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Current issues in adjuvant treatment of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Guidelines 2000 for colon and rectal cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

NCCN Clinical Practice Guidelines in Oncology: colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

The significance of unstable chromosomes in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Loss of heterozygosity: an independent prognostic factor of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Molecular prognostic markers in locally advanced colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Micrometastases and survival in stage II colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Molecular staging for survival prediction of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

RETRACTED: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0324-4

Allelic loss of chromosome 18q and prognosis in colorectal cancer

21 January 2018

1 reference

12 December 2020

Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry

1 reference

12 December 2020

Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence

1 reference

12 December 2020

Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer

1 reference

12 December 2020

Genetic diagnosis of lymph-node metastasis in colorectal cancer

1 reference

12 December 2020

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

1 reference

12 December 2020

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial

1 reference

12 December 2020

Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer

1 reference

12 December 2020

Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes

1 reference

12 December 2020

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients

1 reference

12 December 2020

Stage II colon cancer prognosis prediction by tumor gene expression profiling

1 reference

12 December 2020

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers

1 reference

12 December 2020

Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples

1 reference

12 December 2020

Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients

1 reference

12 December 2020

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

1 reference

12 December 2020

A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer

1 reference

12 December 2020

Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer

1 reference

12 December 2020

Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q

1 reference

12 December 2020

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection

1 reference

12 December 2020

Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer

1 reference

12 December 2020

Dissemination of tumor cells in patients undergoing surgery for colorectal cancer

1 reference

12 December 2020

Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene

1 reference

12 December 2020

Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients

1 reference

12 December 2020

BRAFMutation in Metastatic Colorectal Cancer

1 reference

12 December 2020

Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase

1 reference

12 December 2020

Adjuvant Therapy for completely resected Stage II Colon Cancer

1 reference

12 December 2020

P53 abnormalities and outcomes in colorectal cancer: a systematic review.

1 reference

12 December 2020

10.1007/S00595-012-0324-4

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22961195